Skip to main content

Garg Pushkal's Form 4 filing

Alnylam Pharmaceuticals, Inc. (ALNY) · filed Feb 18, 2025

Accession no.
0001735276-25-000009
Filed
Feb 18, 2025
Trade date
Feb 13-18, 2025
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 19 non-derivative transactions. Open-market sales total $787.9K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Garg PushkalCIK 0001829252Officer (CMO & EVP Dev & Med Affairs)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 13, 2025Common StockAGrant or awardAcquired+3,109$0.00$015,098Direct
Feb 14, 2025Common StockSSaleDisposed−349$252.50F3−$88,122.514,749Direct
Feb 14, 2025Common StockSSaleDisposed−386$253.37F4−$97,800.8214,363Direct
Feb 14, 2025Common StockSSaleDisposed−258$254.35F5−$65,622.314,105Direct
Feb 14, 2025Common StockSSaleDisposed−110$255.56F6−$28,111.613,995Direct
Feb 14, 2025Common StockSSaleDisposed−126$256.29F7−$32,292.5413,869Direct
Feb 14, 2025Common StockSSaleDisposed−60$257.51F8−$15,450.613,809Direct
Feb 14, 2025Common StockSSaleDisposed−77$258.07F9−$19,871.3913,732Direct
Feb 14, 2025Common StockSSaleDisposed−27$259.72F10−$7,012.4413,705Direct
Feb 14, 2025Common StockSSaleDisposed−49$260.57F11−$12,767.9313,656Direct
Feb 14, 2025Common StockSSaleDisposed−60$261.45F12−$15,68713,596Direct
Feb 14, 2025Common StockSSaleDisposed−27$263.33−$7,109.9113,569Direct
Feb 14, 2025Common StockSSaleDisposed−32$264.87−$8,475.8413,537Direct
Feb 18, 2025Common StockSSaleDisposed−862$250.11F14−$215,594.8212,675Direct
Feb 18, 2025Common StockSSaleDisposed−306$250.73F15−$76,723.3812,369Direct
Feb 18, 2025Common StockSSaleDisposed−110$251.60−$27,67612,259Direct
Feb 18, 2025Common StockSSaleDisposed−83$256.05F16−$21,252.1512,176Direct
Feb 18, 2025Common StockSSaleDisposed−107$257.99F17−$27,604.9312,069Direct
Feb 18, 2025Common StockSSaleDisposed−80$259.10−$20,72811,989Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $251.89 to $252.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F4

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $252.90 to $253.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $253.96 to $254.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $254.99 to $255.97. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.01 to $256.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.05 to $257.78. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F9

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.86 to $258.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F10

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $259.21 to $260.14. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F11

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $260.31 to $260.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F12

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $261.42 to $261.47. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F14

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $249.56 to $250.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F15

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $250.57 to $251.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F16

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.00 to $256.95. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F17

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.79 to $258.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)